Clinical and epidemiological characteristics and outcomes of patients hospitalized for COVID-19 in Douala, Cameroon.

David Mekolo, Francois Adrien Bokalli, Fru McWright Chi, Steve Beukou Fonkou, Mbachan Maseoli Takere, Conrald Metuge Ekukole, Jean Moise Bikoy Balomoth, Dickson Shey Nsagha, Noel Emmanuel Essomba, Louis Richard Njock, Marcellin Ngowe Ngowe
Author Information
  1. David Mekolo: Intensive Care and Emergency Department, Laquintinie Hospital, Douala, Cameroon.
  2. Francois Adrien Bokalli: Intensive Care and Emergency Department, Laquintinie Hospital, Douala, Cameroon.
  3. Fru McWright Chi: Department of Medicine, Faculty of Health Sciences, University of Buea, Buea Cameroon.
  4. Steve Beukou Fonkou: Intensive Care and Emergency Department, Laquintinie Hospital, Douala, Cameroon.
  5. Mbachan Maseoli Takere: Department of Medicine, Faculty of Health Sciences, University of Buea, Buea Cameroon.
  6. Conrald Metuge Ekukole: Department of Medicine, Faculty of Health Sciences, University of Buea, Buea Cameroon.
  7. Jean Moise Bikoy Balomoth: Intensive Care and Emergency Department, Laquintinie Hospital, Douala, Cameroon.
  8. Dickson Shey Nsagha: Department of Public Health and Hygiene, Faculty of Health Sciences, University of Buea, Buea Cameroon.
  9. Noel Emmanuel Essomba: Intensive Care and Emergency Department, Laquintinie Hospital, Douala, Cameroon.
  10. Louis Richard Njock: Department of Surgery and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.
  11. Marcellin Ngowe Ngowe: Department of Surgery and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.

Abstract

INTRODUCTION: the coronavirus disease (COVID-19) is a disease that originated from Wuhan in December 2019. It rapidly spread across the globe causing high mortality especially among the elderly. Africa though not spared has limited studies regarding its effects on its population. We therefore sought to describe the epidemiological and clinical characteristics of COVID-19 in Douala, Cameroon.
METHODS: we conducted a single-centre, retrospective, and observational study by reviewing records of patients managed for COVID-19 between the 8 March 2020 and 31, May 2020. Cases were confirmed by real-time reverse transcriptase - polymerase chain reaction and were analysed for epidemiological, demographic, clinical, and radiological features. Outcomes were either clinical improvement by Day-28 or in-hospital mortality.
RESULTS: we analyzed 282 case files, 192 were males (M: F=2: 1). The mean age was 52 (+/- 15) years. Hypertension and diabetes accounted for 75% of the chronic medical conditions identified. Main presenting complaints were dyspnea, cough, asthenia, and fever (55-60%). Radiographic analysis showed a ground-glass appearance in 85% of cases. Chloroquine/Hydroxychloroquine was the most (91.8%) frequently used drug in management protocols, 35% needed oxygen supplementation while 6 patients were intubated. Severe pneumonia (11.3%) was the commonest complication. They were 91 admissions in the intensive care unit. The average length of hospital stay was 10 (+/- 5) days. The mortality rate was 32%.
CONCLUSION: our findings are concordant with universally reported data of COVID-19 hospitalised patients. These parameters are essential in designing effective prevention and control programs aimed at reducing the impact of the COVID-19 pandemic particularly in countries with limited resources.

Keywords

References

  1. Am J Trop Med Hyg. 2020 Dec;103(6):2419-2428 [PMID: 33009770]
  2. Pan Afr Med J. 2020 Jul 24;35(Suppl 2):122 [PMID: 33282077]
  3. Lancet Infect Dis. 2020 Dec;20(12):1367-1368 [PMID: 32618280]
  4. Pan Afr Med J. 2020 Jun 15;35(Suppl 2):77 [PMID: 33623601]
  5. Trop Med Int Health. 2020 Mar;25(3):278-280 [PMID: 32052514]
  6. Rev Francoph Lab. 2020 Nov;2020(526):40-47 [PMID: 33163103]
  7. Eur J Radiol. 2020 May;126:108961 [PMID: 32229322]
  8. Lancet. 2020 Feb 15;395(10223):497-506 [PMID: 31986264]
  9. Lancet. 2020 Feb 15;395(10223):507-513 [PMID: 32007143]
  10. J Community Health. 2021 Jun;46(3):457-470 [PMID: 32638198]
  11. Lancet Respir Med. 2020 May;8(5):475-481 [PMID: 32105632]
  12. JAMA Intern Med. 2020 Oct 1;180(10):1345-1355 [PMID: 32667669]
  13. Ethiop J Health Sci. 2020 Sep;30(5):645-652 [PMID: 33911824]
  14. N Engl J Med. 2020 Apr 30;382(18):1708-1720 [PMID: 32109013]
  15. Pan Afr Med J. 2020 May 13;35(Suppl 2):34 [PMID: 33623559]
  16. Ghana Med J. 2020 Dec;54(4 Suppl):5-15 [PMID: 33976436]
  17. Lancet. 2020 Mar 28;395(10229):1054-1062 [PMID: 32171076]
  18. Lancet. 2020 Jun 6;395(10239):1763-1770 [PMID: 32442528]
  19. Monaldi Arch Chest Dis. 2020 Apr 10;90(1): [PMID: 32290644]
  20. Pan Afr Med J. 2020 Sep 11;37(Suppl 1):7 [PMID: 33294108]
  21. Chin Med J (Engl). 2020 May 5;133(9):1025-1031 [PMID: 32044814]

MeSH Term

Adult
Aged
COVID-19
Cameroon
Female
Hospitalization
Humans
Intensive Care Units
Length of Stay
Male
Middle Aged
Real-Time Polymerase Chain Reaction
Retrospective Studies
Reverse Transcriptase Polymerase Chain Reaction
Young Adult
COVID-19 Drug Treatment

Word Cloud

Created with Highcharts 10.0.0COVID-19clinicalpatientsmortalityepidemiologicalcharacteristicsCameroondiseaselimitedDouala2020+/-91outcomesINTRODUCTION:coronavirusoriginatedWuhanDecember2019rapidlyspreadacrossglobecausinghighespeciallyamongelderlyAfricathoughsparedstudiesregardingeffectspopulationthereforesoughtdescribeMETHODS:conductedsingle-centreretrospectiveobservationalstudyreviewingrecordsmanaged8March31MayCasesconfirmedreal-timereversetranscriptase-polymerasechainreactionanalyseddemographicradiologicalfeaturesOutcomeseitherimprovementDay-28in-hospitalRESULTS:analyzed282casefiles192malesM:F=2:1meanage5215yearsHypertensiondiabetesaccounted75%chronicmedicalconditionsidentifiedMainpresentingcomplaintsdyspneacoughastheniafever55-60%Radiographicanalysisshowedground-glassappearance85%casesChloroquine/Hydroxychloroquine8%frequentlyuseddrugmanagementprotocols35%neededoxygensupplementation6intubatedSeverepneumonia113%commonestcomplicationadmissionsintensivecareunitaveragelengthhospitalstay105daysrate32%CONCLUSION:findingsconcordantuniversallyreporteddatahospitalisedparametersessentialdesigningeffectivepreventioncontrolprogramsaimedreducingimpactpandemicparticularlycountriesresourcesClinicalhospitalizedepidemiology

Similar Articles

Cited By